These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 20878670

  • 1. First-trimester Down syndrome screening: pregnant women's knowledge.
    Dahl K, Hvidman L, Jørgensen FS, Henriques C, Olesen F, Kjaergaard H, Kesmodel US.
    Ultrasound Obstet Gynecol; 2011 Aug; 38(2):145-51. PubMed ID: 20878670
    [Abstract] [Full Text] [Related]

  • 2. Knowledge of prenatal screening and psychological management of test decisions.
    Dahl K, Hvidman L, Jørgensen FS, Kesmodel US.
    Ultrasound Obstet Gynecol; 2011 Aug; 38(2):152-7. PubMed ID: 20954167
    [Abstract] [Full Text] [Related]

  • 3. Effects of knowledge, education, and experience on acceptance of first trimester screening for chromosomal anomalies.
    Stefansdottir V, Skirton H, Jonasson K, Hardardottir H, Jonsson JJ.
    Acta Obstet Gynecol Scand; 2010 Jul; 89(7):931-8. PubMed ID: 20235896
    [Abstract] [Full Text] [Related]

  • 4. Women's opinions on the offer and use of nuchal translucency screening for Down syndrome.
    Müller MA, Bleker OP, Bonsel GJ, Bilardo CM.
    Prenat Diagn; 2006 Feb; 26(2):105-11. PubMed ID: 16463289
    [Abstract] [Full Text] [Related]

  • 5. The provision of information and informed decision-making on prenatal screening for Down syndrome: a questionnaire- and register-based survey in a non-selected population.
    Schoonen M, Wildschut H, Essink-Bot ML, Peters I, Steegers E, de Koning H.
    Patient Educ Couns; 2012 Jun; 87(3):351-9. PubMed ID: 22030253
    [Abstract] [Full Text] [Related]

  • 6. How important is consent in maternal serum screening for Down syndrome in France? Information and consent evaluation in maternal serum screening for Down syndrome: a French study.
    Favre R, Duchange N, Vayssière C, Kohler M, Bouffard N, Hunsinger MC, Kohler A, Mager C, Neumann M, Vayssière C, Viville B, Hervé C, Moutel G.
    Prenat Diagn; 2007 Mar; 27(3):197-205. PubMed ID: 17238219
    [Abstract] [Full Text] [Related]

  • 7. Expectation and knowledge of women undergoing first-trimester combined screening for Down syndrome in a Chinese population.
    Chan LW, Chau MC, Leung TY, Fung TY, Leung TN, Lau TK.
    Prenat Diagn; 2005 Dec; 25(13):1248-52. PubMed ID: 16353273
    [Abstract] [Full Text] [Related]

  • 8. Do pregnant women in Greece make informed choices about antenatal screening for Down's syndrome? A questionnaire survey.
    Gourounti K, Sandall J.
    Midwifery; 2008 Jun; 24(2):153-62. PubMed ID: 17316936
    [Abstract] [Full Text] [Related]

  • 9. Pregnant women's attitudes toward amniocentesis before receiving Down syndrome screening results.
    Brajenović-Milić B, Babić I, Ristić S, Vraneković J, Brumini G, Kapović M.
    Womens Health Issues; 2008 Jun; 18(2):79-84. PubMed ID: 18180167
    [Abstract] [Full Text] [Related]

  • 10. A survey of the knowledge and attitudes of pregnant Thai women towards Down syndrome screening.
    Pruksanusak N, Suwanrath C, Kor-Anantakul O, Prasartwanakit V, Leetanaporn R, Suntharasaj T, Hanprasertpong T.
    J Obstet Gynaecol Res; 2009 Oct; 35(5):876-81. PubMed ID: 20149035
    [Abstract] [Full Text] [Related]

  • 11. [Pregnant women's assessment and level of knowledge of prenatal counseling].
    Tschudin S, Holzgreve W, Conde N, Alder J, Bitzer J, Tercanli S.
    Ultraschall Med; 2009 Apr; 30(2):157-62. PubMed ID: 18484059
    [Abstract] [Full Text] [Related]

  • 12. 'This is just what you do when you are pregnant': a qualitative study of prospective parents in Iceland who accept nuchal translucency screening.
    Gottfredsdóttir H, Sandall J, Björnsdóttir K.
    Midwifery; 2009 Dec; 25(6):711-20. PubMed ID: 18295382
    [Abstract] [Full Text] [Related]

  • 13. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ, Dickinson JE, O'Leary P, Bower C, Goldblatt J, Hewitt B, Murch A, Stock R.
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [Abstract] [Full Text] [Related]

  • 14. Women's perception of information and experiences of nuchal translucency screening in Greece.
    Gourounti K, Lykeridou K, Daskalakis G, Glentis S, Sandall J, Antsaklis A.
    Fetal Diagn Ther; 2008 Dec; 24(2):86-91. PubMed ID: 18648204
    [Abstract] [Full Text] [Related]

  • 15. Audiovisual information affects informed choice and experience of information in antenatal Down syndrome screening--a randomized controlled trial.
    Björklund U, Marsk A, Levin C, Öhman SG.
    Patient Educ Couns; 2012 Mar; 86(3):390-5. PubMed ID: 21807474
    [Abstract] [Full Text] [Related]

  • 16. Are pregnant Australian women well informed about prenatal genetic screening? A systematic investigation using the Multidimensional Measure of Informed Choice.
    Rowe HJ, Fisher JR, Quinlivan JA.
    Aust N Z J Obstet Gynaecol; 2006 Oct; 46(5):433-9. PubMed ID: 16953859
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [A qualitative study of pregnant women's choice of nuchal translucency measurement].
    Lou S, Dahl K, Risør MB, Hvidman LE, Thomsen SG, Jørgensen FS, Olesen F, Kjaergaard H, Kesmodel U.
    Ugeskr Laeger; 2007 Mar 05; 169(10):914-8. PubMed ID: 17359736
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.